# Bank7 Corp.: overview BSVN · Nasdaq · CIK 1746129 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/bsvn.md) · [Financials](/companies/bsvn/financials.md) · [Filings](/companies/bsvn/filings.md) · [Insiders](/companies/bsvn/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [1.24](/filings/0001140361-25-041162.md) | not reported | [1.08](/filings/0001140361-26-020594.md) | [1.16](/filings/0001140361-26-032024.md) | [1.13](/filings/0001140361-25-041162.md) | not reported | [1.25](/filings/0001140361-26-020594.md) | [0.87](/filings/0001140361-26-032024.md) | | Free cash flow | $m | [12.7 d](/filings/0001140361-25-041162.md) | [11.8 d](/filings/0001140361-26-009657.md) | [8.2](/filings/0001140361-26-020594.md) | [8.8 d](/filings/0001140361-26-032024.md) | [16.4 d](/filings/0001140361-25-041162.md) | [8.0 d](/filings/0001140361-26-009657.md) | [14.2](/filings/0001140361-26-020594.md) | [5.4 d](/filings/0001140361-26-032024.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [2.55](/filings/0001140361-24-014984.md) | [3.22](/filings/0001140361-25-008438.md) | [3.05](/filings/0001140361-26-009657.md) | [4.84](/filings/0001140361-26-009657.md) | [4.50](/filings/0001140361-26-009657.md) | | Free cash flow | $m | [29.5](/filings/0001140361-24-014984.md) | [39.4](/filings/0001140361-25-008438.md) | [46.3](/filings/0001140361-26-009657.md) | [50.8](/filings/0001140361-26-009657.md) | [41.4](/filings/0001140361-26-009657.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bsvn/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $28.9m | 591,019 | | Added +84,399 | | [Mink Brook Asset Management LLC](/funds/2052205.md) | 2026-06-30 | $23.3m | 475,610 | | Added +2,950 | | [MANUFACTURERS LIFE INSURANCE COMPANY, THE](/funds/928047.md) | 2026-06-30 | $13.4m | 274,577 | | Reduced −1,999 | | [Twin Lions Management LLC](/funds/2055318.md) | 2026-06-30 | $12.5m | 255,197 | | Reduced −68,162 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $9.6m | 195,467 | | Added +2,471 | | [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $7.1m | 145,943 | | Added +10,034 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $7.0m | 142,520 | | Added +7,360 | | [BANC FUNDS CO LLC](/funds/1029311.md) | 2026-06-30 | $6.3m | 128,519 | | Unchanged | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $5.5m | 112,583 | | Added +14,602 | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $3.6m | 74,192 | | Added +1,722 | ## Recent filings [All 492 filings](/companies/bsvn/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-15 | 08:00 ET | [8-K](/filings/0001140361-26-039667.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-039667 | | 2026-10-09 | 15:52 ET | [8-K](/filings/0001140361-26-039264.md) | 8.01 Other events | 0001140361-26-039264 | | 2026-09-17 | 07:30 ET | [8-K](/filings/0001140361-26-036855.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-036855 | | 2026-09-10 | 16:30 ET | [8-K](/filings/0001140361-26-036192.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-036192 | | 2026-09-03 | 16:05 ET | [8-K](/filings/0001140361-26-035571.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-035571 | | 2026-08-10 | 16:16 ET | [10-Q](/filings/0001140361-26-032024.md) | Quarterly report, period 2026-06-30 | 0001140361-26-032024 | | 2026-07-16 | 08:00 ET | [8-K](/filings/0001140361-26-028609.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-028609 | | 2026-07-02 | 17:00 ET | [8-K](/filings/0001140361-26-027463.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-027463 | | 2026-05-21 | 16:36 ET | [8-K](/filings/0001140361-26-022462.md) | 5.07 Shareholder vote results | 0001140361-26-022462 | | 2026-05-11 | 16:35 ET | [10-Q](/filings/0001140361-26-020594.md) | Quarterly report, period 2026-03-31 | 0001140361-26-020594 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001140361-26-009657.md), filed Mar 17, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1746129 - Tickers: BSVN - Exchange: Nasdaq - SIC code: 6022 State Commercial Banks - State of incorporation: not reported - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Nov 2, 2026, 09:01 ET. No prices; not investment advice.